Patterns of Neonatal and Neurodevelopmental Comorbidities in Neonates of <29 Weeks' Gestation

Prakesh S Shah1,2, Thuy Mai Luu3,4, Marc Beltempo5,6

  • 1Department of Pediatrics, Mount Sinai Hospital, Toronto, Ontario, Canada, prakeshkumar.shah@sinaihealth.ca.

Neonatology
|January 22, 2026
PubMed

Insights

Most preterm infants born before 29 weeks gestation had no adverse neonatal outcomes. However, neonatal morbidities significantly increased the risk of neurodevelopmental impairment in survivors.

Area of Science:

  • Neonatalogy
  • Developmental Pediatrics
  • Epidemiology

Background:

  • Multi-morbidity is linked to poor outcomes and high healthcare costs in adults.
  • Understanding neonatal co-morbidities is crucial for preterm infant care.

Purpose of the Study:

  • To investigate the co-occurrence of neonatal morbidities in preterm infants.
  • To determine the association between neonatal morbidities and neurodevelopmental outcomes in very preterm neonates.

Main Methods:

  • Analysis of 17,438 preterm neonates (<29 weeks gestation) admitted to Canadian NICUs (2010-2020).
  • Neurodevelopmental outcomes assessed in 7,943 children using Bayley-III scores, cerebral palsy (GMFCS), hearing, and visual impairment.
  • Neonatal outcomes included mortality, late-onset sepsis, necrotizing enterocolitis, and severe neurological injury.

Main Results:

  • 40.1% of infants experienced at least one neonatal mortality or morbidity.
  • Among survivors, 16.3% had significant and 5.8% had severe neurodevelopmental impairment.
  • Late-onset sepsis, necrotizing enterocolitis, and severe neurological injury were associated with significant neurodevelopmental impairment. A higher count of neonatal morbidities correlated with more neurodevelopmental impairments.

Conclusions:

  • 60% of infants born before 29 weeks gestation had no adverse neonatal outcomes.
  • The majority of survivors were free from significant neurodevelopmental impairment.
  • Neonatal morbidities directly and cumulatively impact neurodevelopmental outcomes in preterm infants.

Related Concept Videos

Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...
40.4K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
75